Auvigne V, Tamandjou Tchuem CR, Schaeffer J, Vaux S, et al. Protection against symptomatic SARS-CoV-2 infection conferred by the Pfizer-BioNTech Original/BA.4-5 bivalent vaccine compared to the mRNA Original monovalent vaccines - A matched cohort study in France. Vaccine 2023 Aug 2:S0264-410X(23)00917-9. doi: 10.1016/j.vaccine.2023.
PMID: 37541823